1. Home
  2. NNDM vs XFOR Comparison

NNDM vs XFOR Comparison

Compare NNDM & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.74

Market Cap

368.1M

Sector

Technology

ML Signal

HOLD

Logo X4 Pharmaceuticals Inc.

XFOR

X4 Pharmaceuticals Inc.

HOLD

Current Price

$4.23

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
XFOR
Founded
2012
2014
Country
United States
United States
Employees
N/A
143
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.1M
407.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NNDM
XFOR
Price
$1.74
$4.23
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
2.4M
417.2K
Earning Date
03-31-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$102,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
77.30
N/A
52 Week Low
$1.31
$0.17
52 Week High
$2.32
$6.63

Technical Indicators

Market Signals
Indicator
NNDM
XFOR
Relative Strength Index (RSI) 50.75 55.04
Support Level $1.70 $3.46
Resistance Level $1.87 $4.52
Average True Range (ATR) 0.09 0.29
MACD 0.01 -0.01
Stochastic Oscillator 56.00 65.43

Price Performance

Historical Comparison
NNDM
XFOR

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Share on Social Networks: